Study questions botulinum's efficacy in post-BPH overactive bladder

Intradetrusor injections of onabotulinumtoxinA (Botox) do not significantly reduce urinary frequency in patients with refractory overactive bladder secondary to BPH, results from a two-institution, placebo-controlled study indicate.
Source: Modern Medicine - Category: Journals (General) Source Type: news